These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 21356265)
61. CYP2C9 and OATP1B1 genetic polymorphisms affect the metabolism and transport of glimepiride and gliclazide. Yang F; Xiong X; Liu Y; Zhang H; Huang S; Xiong Y; Hu X; Xia C Sci Rep; 2018 Jul; 8(1):10994. PubMed ID: 30030468 [TBL] [Abstract][Full Text] [Related]
62. Exploring the Role of Phenylalanine Residues in Modulating the Flexibility and Topography of the Active Site in the Peroxygenase Variant PaDa-I. Ramirez-Ramirez J; Martin-Diaz J; Pastor N; Alcalde M; Ayala M Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785123 [TBL] [Abstract][Full Text] [Related]
63. Glutamine-451 Confers Sensitivity to Oxidative Inhibition and Heme-Thiolate Sulfenylation of Cytochrome P450 4B1. Albertolle ME; Song HD; Wilkey CJ; Segrest JP; Guengerich FP Chem Res Toxicol; 2019 Mar; 32(3):484-492. PubMed ID: 30701961 [TBL] [Abstract][Full Text] [Related]
64. Identification of variable amino acids in the SRS1 region of CYP6B1 modulating furanocoumarin metabolism. Pan L; Wen Z; Baudry J; Berenbaum MR; Schuler MA Arch Biochem Biophys; 2004 Feb; 422(1):31-41. PubMed ID: 14725855 [TBL] [Abstract][Full Text] [Related]
65. Molecular dynamics simulation of Autotaxin: roles of the nuclease-like domain and the glycan modification. Koyama M; Nishimasu H; Ishitani R; Nureki O J Phys Chem B; 2012 Oct; 116(39):11798-808. PubMed ID: 22967301 [TBL] [Abstract][Full Text] [Related]
66. Hydrotropic Action of Cationic Hydrotrope p-Toluidinium Chloride on the Solubility of Sparingly Soluble Gliclazide Drug Molecule: A Computational Study. Das S; Paul S J Chem Inf Model; 2017 Jun; 57(6):1461-1473. PubMed ID: 28530396 [TBL] [Abstract][Full Text] [Related]
67. Investigation by MD simulation of the key residues related to substrate-binding and heme-release in human ferrochelatase. Wang Y; Wu J; Ju J; Shen Y J Mol Model; 2013 Jun; 19(6):2509-18. PubMed ID: 23446439 [TBL] [Abstract][Full Text] [Related]
68. Dynamics of heme complexed with human serum albumin: a theoretical approach. Cuya Guizado TR; Louro SR; Anteneodo C Eur Biophys J; 2012 Dec; 41(12):1033-42. PubMed ID: 23104623 [TBL] [Abstract][Full Text] [Related]
69. Interaction of drugs amlodipine and paroxetine with the metabolizing enzyme CYP2B4: a molecular dynamics simulation study. Yousefpour A; Modarress H; Goharpey F; Amjad-Iranagh S J Mol Model; 2018 Feb; 24(3):67. PubMed ID: 29476269 [TBL] [Abstract][Full Text] [Related]
70. Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9. Cojocaru V; Winn PJ; Wade RC Curr Drug Metab; 2012 Feb; 13(2):143-54. PubMed ID: 22208529 [TBL] [Abstract][Full Text] [Related]
71. Gliclazide. Parvez M; Arayne MS; Zaman MK; Sultana N Acta Crystallogr C; 1999 Jan; 55 ( Pt 1)():74-5. PubMed ID: 10048179 [TBL] [Abstract][Full Text] [Related]
72. Modeling of transition state by molecular dynamics. Prediction of catalytic efficiency of the mutants of mandelate racemase. Zhuohang M; Ji L; Hongwei Y J Biomol Struct Dyn; 2011 Jun; 28(6):871-9. PubMed ID: 21469748 [TBL] [Abstract][Full Text] [Related]
73. Reduced Catalytic Activity of P450 2A6 Mutants with Coumarin: A Computational Investigation. Li W; Ode H; Hoshino T; Liu H; Tang Y; Jiang H J Chem Theory Comput; 2009 May; 5(5):1411-20. PubMed ID: 26609728 [TBL] [Abstract][Full Text] [Related]
74. Computational investigation of cis-1,4-polyisoprene binding to the latex-clearing protein LcpK30. Abu Hassan A; Hanževački M; Pordea A PLoS One; 2024; 19(5):e0302398. PubMed ID: 38748648 [TBL] [Abstract][Full Text] [Related]
76. Structural dynamics of the cooperative binding of small inhibitors in human cytochrome P450 2C9. Cai J; Shi R J Mol Graph Model; 2022 Jun; 113():108151. PubMed ID: 35168147 [TBL] [Abstract][Full Text] [Related]
77. An Artificial Heme Enzyme for Cyclopropanation Reactions. Villarino L; Splan KE; Reddem E; Alonso-Cotchico L; Gutiérrez de Souza C; Lledós A; Maréchal JD; Thunnissen AWH; Roelfes G Angew Chem Int Ed Engl; 2018 Jun; 57(26):7785-7789. PubMed ID: 29719099 [TBL] [Abstract][Full Text] [Related]
78. Assessment of CYP2C9 Structural Models for Site of Metabolism Prediction. Zhang X; Xu M; Wu Z; Liu G; Tang Y; Li W ChemMedChem; 2021 Jun; 16(11):1754-1763. PubMed ID: 33600055 [TBL] [Abstract][Full Text] [Related]
79. Molecular dynamics characterization of five pathogenic Factor X mutants associated with decreased catalytic activity. Abdel-Azeim S; Oliva R; Chermak E; De Cristofaro R; Cavallo L Biochemistry; 2014 Nov; 53(44):6992-7001. PubMed ID: 25313940 [TBL] [Abstract][Full Text] [Related]